ARCHIVES

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

This article is from The Cancer Letter archive.

Vol. 37 No. 14 | April 8, 2011

Download PDF Visit The Full Archive

Related Articles

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

Russian-American Breast Cancer Meeting Canceled

April 14, 1995

Surgical Oncologists Honor HHS Secretary

March 22, 2002

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

September 7, 2012